Oticon Real vs RxEars Rxi

The Oticon Real is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.8/5, placing it in the top 8% of all prescription hearing aids tested and ranking #4 out of 36 devices in its category. Speech performance is a standout strength. Speech in quiet scores an excellent 4.5/5 on initial fit—0.72 points above the category average—while speech in noise scores 3.0/5, nearly a full point above the category average of 1.96/5. While the speech-in-noise result is above average for the category, it remains mixed in absolute terms at 2.9/5 after tuning, reflecting the inherent challenge of noisy environments for all hearing aids. Music streaming quality starts strong at 4.2/5 on initial fit, though it drops to a mixed 2.8/5 after tuning—still slightly above the category average. Feedback handling scores a solid 4.0/5, which is strong in absolute terms, though it falls 0.71 points below the category average of 4.71/5. Own-voice comfort is mixed at 2.4/5, slightly below the category average. The Oticon Real competes directly with other premium devices like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). It offers versatile connectivity with iPhone and Android streaming plus hands-free capabilities, and supports both rechargeable and disposable batteries. This device is best suited for users prioritizing strong out-of-box speech clarity who want a well-rounded premium hearing aid from a trusted manufacturer.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.